Multi-center Biobank and Outcomes Registry for Obesity

Overview

About this study

The purpose of this study is to establish a multi-center biobank and outcomes registry of at least 2000 patients with obesity that allows for a better understanding of demographic, clinical, and biological variables that predict the severity of the disease, the development of weight-related complications, and the weight loss and weight-related complications outcomes in response to obesity interventions.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients 18 years or older with obesity (for adults BMI ≥ 30kg/m^2 or BMI ≥ 27kg/m^2 and at least one obesity-related chronic disease (such as type 2 diabetes mellitus, hypertension, obstructive sleep apnea, amongst others)).
Individuals undergoing an evaluation for weight loss interventions (e.g., diet, medication, bariatric endoscopic procedure, or surgery)

Exclusion Criteria:

Principal investigator discretion.
Individuals who are unable to sign consent (e.g., those declared legally incompetent).
Patients without a tracking device (smart phone or wearable device).

Eligibility last updated 5/3/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
La Crosse, Wis. Mayo Clinic principal investigator Maria Hurtado Andrade, M.D., Ph.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Jessica Stutzman (507) 422-5891 RSTINDIVOBESITY@mayo.edu
Rochester, Minn. Mayo Clinic principal investigator Maria Hurtado Andrade, M.D., Ph.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Jessica Stutzman (507) 422-5891 RSTINDIVOBESITY@mayo.edu
Jacksonville, Fla. Mayo Clinic principal investigator Maria Hurtado Andrade, M.D., Ph.D.	Closed-enrolling by invitation What is this? (?) "Close" Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.	Contact information: Jessica Stutzman (507) 422-5891 RSTINDIVOBESITY@mayo.edu

Mayo Clinic Location

Status

Contact

La Crosse, Wis.

Mayo Clinic principal investigator

Maria Hurtado Andrade, M.D., Ph.D.

Closed-enrolling by invitation

Contact information:

Jessica Stutzman

(507) 422-5891

RSTINDIVOBESITY@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Maria Hurtado Andrade, M.D., Ph.D.

Closed-enrolling by invitation

Contact information:

Jessica Stutzman

(507) 422-5891

RSTINDIVOBESITY@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Maria Hurtado Andrade, M.D., Ph.D.

Closed-enrolling by invitation

Contact information:

Jessica Stutzman

(507) 422-5891

RSTINDIVOBESITY@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials